Toni Choueiri, MD
@DrChoueiri
Followers
43K
Following
39K
Media
4K
Statuses
27K
Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; ⚽ lover; 🚲@PanMass rider.
Boston, MA
Joined January 2016
The @DanaFarber State of the Institute was a very special event ! Sharing the stage with CEO Ben Ebert, MD, PhD + @NobelPrize Laureate William (Bill) Kaelin, Jr MD was special. We discussed the drug journey from Lab ->clinical trial-> approval, all with the #cancerpatient at the
2
16
102
You are probably right, though in many parts of the world, the new SOC may not be available #ESMO25 @myESMO @DFCI_BreastOnc
DB-11 abstract just released. In high-risk (≥T3, N+, or IBC) HER2+ eBC, neoadjuvant T-DXd-THP outperformed ddAC-THP (pCR rate 67% vs 56%, p=0.003), with reduction in cardiotoxicity (LVD 1.9 vs 9%) and low rate of ILD (4.4 vs 5.1%). The last nail in the coffin for anthracyclines.
0
2
10
"That is hard to believe... that a terrorist organization garners nearly 10% of support among the voters for a recent American presidential candidate." @johnrogersal @brentbuc from our latest Pulse Pod episode. 🚨 Shocking data from our September NVT poll. October numbers drop
1
2
26
Can’t miss #ESMO25 =>Practice-changing, Practice-informing and forward-looking data in all cancers ! @myESMO @MyriamChalabi @FAndreMD
🥁#ESMO25 ABSTRACT RELEASE DAY🥁 #ESMO25 is shaping up to be one of most impactful conferences in recent memory with #PracticeChangingData in Prostate, Bladder and Kidney Cancers! 💫See list of highlighted abstracts 👇
0
22
77
The @kidneycan #KCRS2025 abstracts are now all published in @OncJournal
https://t.co/75jb0jZ9nD
@montypal @advocatekidneys @arihakimi @HHammersMD
1
3
14
10 years ago, cancer tried to change my story. Thanks to @DrChoueiri & @DanaFarber_GU I have been given the precious gift of time. Last weekend, I got to hold my first grandson. Thank you @DanaFarber . Grateful beyond words. 💙 #DEFYCANCER @DanaFarber @TheJimmyFund
3
4
41
“My parents could barely read or write. It’s been quite a journey, science allows you to do it.” New laureate Omar Yaghi was in the middle of changing flights when we reached him, just after he heard that he had been awarded the 2025 #NobelPrize in Chemistry. In this interview
417
5K
16K
JUST IN: The Royal Swedish Academy of Sciences has decided to award the 2025 @NobelPrize Prize in Chemistry to Susumu Kitagawa, Richard Robson and Omar M. Yaghi “for the development of metal–organic frameworks.” The 2025 Nobel Prize laureates in chemistry have created molecular
1
12
36
Your Pipedrive journey starts here! Track your sales pipeline with the easy and effective CRM for closing deals.
1
5
32
Dr. @RazaneHChehade is a physician-scientist trained by @DanaFarber_GU @DrChoueiri @SylvanBacaLab for 3 years (Comp Bio) Any Peds Residency Program would be lucky to have her! @StoriesImg @IMG_Oncologists #pedsresidency
I am Razane El Hajj Chehade, an #IMG from 🇱🇧 @USJLiban, postdoc at @DanaFarber with focus on computational biology , epigenetics. Thrilled to apply to #Pediatrics #Match2026🧸 Grateful for the unwavering support of my mentors @DrChoueiri @SylvanBacaLab! AAMC ID: 16746153
1
22
81
Dr. @MarcMachaalani is a physician-scientist trained by @DanaFarber_GU @DrChoueiri for 3 years--Simply exceptional! Any IM Residency Program would be lucky to have him! @StoriesImg @IMG_Oncologists
Hi everyone! I'm Marc Machaalani, IMG from 🇱🇧 and postdoctoral research fellow focusing on kidney cancer at @DanaFarber @harvardmed. Thrilled to be applying to #InternalMedicine for the #Match2026! AAMC ID: 15833270
1
10
66
JUST IN: The Royal Swedish Academy of Sciences has decided to award the 2025 @NobelPrize in Physics to John Clarke, Michel H. Devoret and John M. Martinis “for the discovery of macroscopic quantum mechanical tunnelling and energy quantisation in an electric circuit.”
3
7
27
JUST IN: The 2025 @NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
1
39
183
They said you can't automate your trading strategies on TradingView, but they were wrong. TradersPost is the perfect way to automate your indicators, strategies and prop firm accounts.
8
14
57
When dad (@DrChoueiri) is injured, #ZeinaChoueiri picks it up with her @thayeracademy awesome friends and does the @TheJimmyFund walk to honor @DanaFarber patients and raise money for #cancer #research ! Go @thayeracademy Tigers🐯!
7
11
123
Very nice work in @JCO_ASCO from @VivekSubbiah and team showing in real data the impact of @US_FDA Project Optimus in shaping early Clinical Trials Design. Bravo Vivek !
🚨 Hot off the press in @ASCO journal @JCOOA_ASCO 👉Pleased to share our study 👉 "Impact of FDA Project Optimus Guidance on Design of Early-Phase Clinical Trials" 📊 Analysis of 367 phase I #oncology trials (2021-2024) reveals Project Optimus is transforming cancer drug
1
13
45
Top #GUCancer Oncologists for Q3 2025, curated by @Larvol CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/VJu7MflQA0
#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights #ClinicalTrials | @DrChoueiri |
0
6
18
Top #GUCancer Oncologists for September 2025, curated by @LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/VJu7MflQA0
#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights #ClinicalTrials | @DrChoueiri |
0
6
14
We're honored to be selected for the Techstars + Cardano Founder Catalyst program! The program will benefit us through networking opportunities, refining our products. coaching & mentoring programs. We're excited to continue on this journey with our mentors and fellow founders!
65
68
75
3
22
87
Herculean effort in @NatureMedicine from 🇮🇹 (@Roma) group re: tumor-agnostic oncology strategy. Benefit likely higher w/potent drugs in the future. https://t.co/SYUCAzLkVZ
@curijoey @PAscierto @oncologiaroma @myESMO PS: plz don't confuse @DottBotticelliA with @AndreaBocelli !!!
nature.com
Nature Medicine - In the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by molecular tumor board evaluation and randomization of patients with metastatic solid cancer...
🇮🇹 The ROME trial marks a milestone for Italy’s precision oncology platform: 6 years of dedication, 40 centers, 1,794 patients sequenced. A national effort to bring genomics to the heart of cancer care. @myESMO @IEOufficiale @LaStatale
0
11
37